Kristina Blaslov

564 total citations
43 papers, 416 citations indexed

About

Kristina Blaslov is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Surgery. According to data from OpenAlex, Kristina Blaslov has authored 43 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Oncology and 9 papers in Surgery. Recurrent topics in Kristina Blaslov's work include Diabetes Treatment and Management (15 papers), Diabetes Management and Research (9 papers) and Diabetes and associated disorders (9 papers). Kristina Blaslov is often cited by papers focused on Diabetes Treatment and Management (15 papers), Diabetes Management and Research (9 papers) and Diabetes and associated disorders (9 papers). Kristina Blaslov collaborates with scholars based in Croatia, North Macedonia and United States. Kristina Blaslov's co-authors include Lea Duvnjak, Tomislav Bulum, Ivan Kruljac, Matea Nikolac Perković, Marijana Vučić Lovrenčić, Milan Vrkljan, Nikolina Bašić‐Jukić, Ingrid Prkačin, Petar Kes and Vanja Radišić Biljak and has published in prestigious journals such as The American Journal of Medicine, World Journal of Gastroenterology and Neuroendocrinology.

In The Last Decade

Kristina Blaslov

39 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristina Blaslov Croatia 11 230 99 88 84 54 43 416
Tomislav Bulum Croatia 12 203 0.9× 109 1.1× 86 1.0× 99 1.2× 76 1.4× 86 502
Anna Bohdanowicz-Pawlak Poland 12 150 0.7× 97 1.0× 39 0.4× 58 0.7× 52 1.0× 33 450
Yin-ling Chen China 12 148 0.6× 108 1.1× 98 1.1× 95 1.1× 45 0.8× 22 511
S-L Wang China 8 179 0.8× 69 0.7× 95 1.1× 96 1.1× 111 2.1× 26 513
Elena Izkhakov Israel 11 175 0.8× 36 0.4× 52 0.6× 49 0.6× 63 1.2× 32 378
Noriko Takebe Japan 13 120 0.5× 103 1.0× 75 0.9× 52 0.6× 75 1.4× 23 368
Min Ho Cho South Korea 10 124 0.5× 85 0.9× 67 0.8× 69 0.8× 82 1.5× 25 355
Kazuhiko Matsuzawa Japan 12 182 0.8× 72 0.7× 96 1.1× 158 1.9× 35 0.6× 30 452
Jinshan Wu China 11 153 0.7× 89 0.9× 77 0.9× 145 1.7× 63 1.2× 16 515
Maria Chantal Ponziani Italy 8 185 0.8× 83 0.8× 72 0.8× 76 0.9× 125 2.3× 14 428

Countries citing papers authored by Kristina Blaslov

Since Specialization
Citations

This map shows the geographic impact of Kristina Blaslov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristina Blaslov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristina Blaslov more than expected).

Fields of papers citing papers by Kristina Blaslov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristina Blaslov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristina Blaslov. The network helps show where Kristina Blaslov may publish in the future.

Co-authorship network of co-authors of Kristina Blaslov

This figure shows the co-authorship network connecting the top 25 collaborators of Kristina Blaslov. A scholar is included among the top collaborators of Kristina Blaslov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristina Blaslov. Kristina Blaslov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blaslov, Kristina. (2020). The Association of Subclinical Insulin Resistance with Thyroid Autoimmunity in Euthyroid Individuals. Acta Clinica Croatica. 59(4). 696–702. 7 indexed citations
2.
Kruljac, Ivan, et al.. (2019). Cushing’s Disease in a Patient with MEN 2B Syndrome. The American Journal of Medicine. 133(2). e46–e47. 1 indexed citations
4.
Dumić-Čule, Ivo, Gordana Ivanac, Tomo Lucijanić, et al.. (2018). Type 2 diabetes and osteoporosis: Current knowledge. 4(1). 23–29. 3 indexed citations
5.
Kruljac, Ivan, et al.. (2018). The Role of the Acute Octreotide Suppression Test in Detecting Patients with Neuroendocrine Neoplasms. Neuroendocrinology. 107(3). 284–291. 1 indexed citations
6.
Blaslov, Kristina, et al.. (2018). The prognostic value of red blood cell characteristics on diabetic retinopathy development and progression in type 2 diabetes mellitus. Clinical Hemorheology and Microcirculation. 71(4). 475–481. 17 indexed citations
7.
Blaslov, Kristina, et al.. (2018). Treatment approach to type 2 diabetes: Past, present and future. World Journal of Diabetes. 9(12). 209–219. 64 indexed citations
9.
Milenković, Tatjana, et al.. (2017). Prediabetes awareness among Southeastern European physicians. Journal of Diabetes Investigation. 9(3). 544–548. 4 indexed citations
10.
Duvnjak, Lea, et al.. (2016). Persons with latent autoimmune diabetes in adults express higher dipeptidyl peptidase-4 activity compared to persons with type 2 and type 1 diabetes. Diabetes Research and Clinical Practice. 121. 119–126. 16 indexed citations
12.
Duvnjak, Lea & Kristina Blaslov. (2016). Dipeptidyl peptidase-4 inhibitors improve arterial stiffness, blood pressure, lipid profile and inflammation parameters in patients with type 2 diabetes mellitus. Diabetology & Metabolic Syndrome. 8(1). 26–26. 42 indexed citations
13.
Blaslov, Kristina, Tomislav Bulum, & Lea Duvnjak. (2015). The role of endothelial dysfunction driven by adipocitokines in the development and progression of microvascular complications in patients with type 1 and type 2 diabetes. Medical Hypotheses. 84(6). 593–595. 8 indexed citations
14.
Blaslov, Kristina, Tomislav Bulum, & Lea Duvnjak. (2014). [Pathophysiological factors in the development of diabetic nephropathy--new insights].. PubMed. 68(2). 135–40. 2 indexed citations
15.
Blaslov, Kristina. (2014). Incretin based therapies: A novel treatment approach for non-alcoholic fatty liver disease. World Journal of Gastroenterology. 20(23). 7356–7356. 31 indexed citations
16.
Blaslov, Kristina, et al.. (2014). Fasting serum dipeptidyl peptidase-4 activity is independently associated with alanine aminotransferase in type 1 diabetic patients. Clinical Biochemistry. 48(1-2). 39–43. 4 indexed citations
18.
Bulum, Tomislav, Kristina Blaslov, & Lea Duvnjak. (2014). Risk factors for development and progression of nonproliferative retinopathy in normoalbuminuric patients with type 1 diabetes. Diabetes Research and Clinical Practice. 106(3). 555–559. 7 indexed citations
19.
Blaslov, Kristina, et al.. (2013). What is the impact of immunosuppressive treatment on the post-transplant renal osteopathy?. International Urology and Nephrology. 46(5). 1019–1024. 8 indexed citations
20.
Blaslov, Kristina, et al.. (2013). Relationship between Adiponectin Level, Insulin Sensitivity, and Metabolic Syndrome in Type 1 Diabetic Patients. International Journal of Endocrinology. 2013. 1–6. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026